Mass spectrometry continues to deliver gains in speed, sensitivity, and analytical depth. Yet the experts interviewed at ASMS argue that technical performance alone does not define meaningful innovation. The next phase of progress will depend on how well vendors understand laboratory needs and convert new capabilities into accessible, reliable workflows.
Customer involvement plays a central role in that process. Instead of developing an instrument in isolation and requesting feedback near launch, vendors can involve users when early prototypes become functional. Scientists can test their own samples, assess the workflow in their laboratories, and identify changes that would deliver practical value. This iterative approach helps development teams distinguish an interesting technical feature from an improvement that transforms daily work. In some cases, a simple change can cut assay time or remove a persistent bottleneck.
Artificial intelligence and automation offer major opportunities to build on this customer-led model. AI could simplify method setup, instrument operation, troubleshooting, and data interpretation. Machine-learning tools can help diagnose problems and guide users toward solutions, reducing downtime and dependence on specialist knowledge. Natural-language interfaces could also make software easier to navigate for scientists who use mass spectrometry as part of their research but do not identify as mass spectrometrists.
Automation must extend beyond the instrument. The experts envision connected workflows that encompass sample preparation, separation, detection, and data processing. Some laboratories want systems that can operate with little or no operator intervention. Achieving that goal will require robust hardware, integrated software, automated sample handling, and reliable decision-making across the workflow.
These advances grow more important as mass spectrometry generates larger and more complex datasets. Emerging applications are moving analysis beyond small peptides toward intact proteins and proteoforms, while imaging and ion-mobility techniques add new dimensions of information. Researchers need tools that can turn these data into clear biological or clinical insights. AI-assisted interpretation could shorten that path, but laboratories will also need standardized methods that transfer cutting-edge research workflows into routine use across sites.
Cost remains a defining constraint. Academic laboratories, government organizations, and core facilities face tighter funding and delays in securing resources. They expect new instruments to support a broader range of applications, withstand changing workloads, and provide a strong return on investment. Vendors must balance annual improvements in capability with the economic realities that shape purchasing decisions.
Taken together, the insights present a practical vision for the future of mass spectrometry. Progress will come from instruments that do more than produce better data. Successful systems will fit laboratory workflows, reduce barriers for non-specialists, translate complexity into useful answers, and remain versatile enough to justify their cost. Customer insight will determine which innovations achieve those goals—and which remain impressive ideas without measurable impact.
